Select Publications

Conference Papers

Rakhshanda S; Liaw ST; Rhee J; Rye KA; Jonnagaddala J, 2024, 'Strategies to Improve Statin Medication Adherence Among Patients at Risk of Cardiovascular Disease Identified Through Electronic Health Records: A Literature Review', in Studies in health technology and informatics, pp. 986 - 990, http://dx.doi.org/10.3233/SHTI231112

Vaidya K; Tucker BJ; Kurup R; Khandkar C; Barraclough J; Misra A; Kavurma M; Martinez G; Rye K-A; Patel S; Cochran BJ, 2020, 'COLCHICINE INHIBITS NEUTROPHIL EXTRACELLULAR TRAP FORMATION IN ACUTE CORONARY SYNDROME PATIENTS POST PERCUTANEOUS CORONARY INTERVENTION', in ATHEROSCLEROSIS, ELSEVIER IRELAND LTD, pp. E6 - E6, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000748958900015&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Manandhar B; Cochran B; Rye K-A, 2020, 'Apolipoprotein A-I Increases Pancreatic beta-cell Insulin Secretion Bv Inhibiting Cholesterol-induced Oxidative Stress in Mitochondria', in ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, LIPPINCOTT WILLIAMS & WILKINS, ELECTR NETWORK, presented at American-Heart-Association's Scientific Sessions on Vascular Discovery - From Genes to Medicine, ELECTR NETWORK, 05 May 2020 - 07 May 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000607042600078&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ong KL; McClelland RL; Allison MA; Kokkinos J; Wu BJ; Barter PJ; Rye K-A, 2018, 'Association of Elevated Circulating Fibroblast Growth Factor 21 Levels With Prevalent and Incident Metabolic Syndrome: The Multi-Ethnic Study of Atherosclerosis.', in CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000528619400097&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ong KL; Hui N; Januszewski AS; Kaakoush NO; Xu A; Fayyad R; DeMicco DA; Jenkins AJ; Keech AC; Waters DD; Barter PJ; Rye K-A, 2018, 'Relationship of FGF21 Levels With Major Cardiovascular Events in Patients Treated With Atorvastatin (From the Treating to New Targets [TNT] Study).', in CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000528619400450&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Cochran BJ; Trajanovska S; Sunn N; Rye KA; Ryder WJ, 2018, 'Development of 3D printing filaments for bespoke X-Ray phantoms', in 2018 IEEE Nuclear Science Symposium and Medical Imaging Conference, NSS/MIC 2018 - Proceedings, http://dx.doi.org/10.1109/NSSMIC.2018.8824621

Kopecky CM; Ryder WJ; Szajer J; Parmar A; Pandzic E; Rye KA; Cochran BJ, 2018, 'Translocator Protein as Novel Marker for Early Atherosclerosis', in ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, LIPPINCOTT WILLIAMS & WILKINS, CA, San Francisco, presented at Scientific Sessions of the American-Heart-Association on Vascular Discovery - From Genes to Medicine, CA, San Francisco, 10 May 2018 - 12 May 2018, http://dx.doi.org/10.1161/atvb.38.suppl_1.222

Rawther T; Torres LFC; Rye KA; Tabet F, 2018, 'REGULATION OF LIPOPROTEIN(A) EXPRESSION BY MICRORNAS IN HUMAN HEPATOMA CELL LINE HEP3B', in ATHEROSCLEROSIS, ELSEVIER IRELAND LTD, PORTUGAL, Lisbon, pp. E160 - E160, presented at 86th Congress of the European-Atherosclerosis-Society (EAS), PORTUGAL, Lisbon, 05 May 2018 - 08 May 2018, http://dx.doi.org/10.1016/j.atherosclerosis.2018.06.479

Arsenault B; Tabet F; Bao W; Petrides F; Hovingh GK; Boekholdt SM; DeMicco D; Rye KA; Waters D; Kastelein J; Barter P; Lambert G, 2016, 'IMPACT OF DIABETES, INSULIN RESISTANCE AND CETP INHIBITION ON CIRCULATING PCSK9 LEVELS IN PATIENTS AT HIGH CARDIOVASCULAR RISK: THE ILLUMINATE STUDY', in ATHEROSCLEROSIS, ELSEVIER IRELAND LTD, AUSTRIA, Innsbruck, pp. E245 - E246, presented at Congress of the European-Atherosclerosis-Society (EAS), AUSTRIA, Innsbruck, 29 May 2016 - 01 June 2016, http://dx.doi.org/10.1016/j.atherosclerosis.2016.07.043

Tabet F; Hou L; Cochran B; Torres LFC; Barter PJ; Rye KA, 2016, 'LIPIDS AND LIPOPROTEINS. BETA CELL-SPECIFIC DELETION OF ABCA1 AND ABCG1 REGULATES THE INCREASE OF SMALL NUCLEOLAR RNAS IN ADIPOCYTES', in ATHEROSCLEROSIS, ELSEVIER IRELAND LTD, AUSTRIA, Innsbruck, pp. E199 - E199, presented at Congress of the European-Atherosclerosis-Society (EAS), AUSTRIA, Innsbruck, 29 May 2016 - 01 June 2016, http://dx.doi.org/10.1016/j.atherosclerosis.2016.07.112

Kontush A; Tubeuf E; Le Goff W; Dauteuille C; Guillas-Baudouin I; Lhomme M; Patel M; Huby T; Chapman MJ; Rye KA; Lesnik P, 2015, 'PHOSPHATIDYLSERINE POTENTLY ENHANCES ANTI-INFLAMMATORY ACTIVITIES OF RECONSTITUTED HDL', in ATHEROSCLEROSIS, ELSEVIER IRELAND LTD, SCOTLAND, Glasgow, pp. E30 - E30, presented at 83rd Congress of the European-Atherosclerosis-Society (EAS), SCOTLAND, Glasgow, 22 March 2015 - 25 March 2015, http://dx.doi.org/10.1016/j.atherosclerosis.2015.04.112

Van der Vorst EPC; Theodorou K; Plat J; Van Eck M; Rye KA; Bursill CA; Tas SW; De Winther MPJ; Biessen EAL; Donners MMPC, 2014, 'High density lipoproteins exert pro-inflammatory effects on macrophages via IKK2-and NIK-independent NF-kB activation', in CARDIOVASCULAR RESEARCH, OXFORD UNIV PRESS, SPAIN, Barcelona, presented at 3rd Congress of the ESC-Council-on-Basic-Cardiovascular-Science on Frontiers in Cardio Vascular Biology, SPAIN, Barcelona, 04 July 2014 - 06 July 2014, http://dx.doi.org/10.1093/cvr/cvu075.2

Tabet F; Vickers KC; Torres LFC; Ammori B; Yadav R; Hama S; Liu Y; Schofield J; Barter P; Soran H; Rye KA, 2014, 'EFFECT OF BARIATRIC SURGERY ON HDL-ASSOCIATED MICRORNAS', in ATHEROSCLEROSIS, ELSEVIER IRELAND LTD, SPAIN, Spanish Soc Atherosclerosis, Madrid, pp. E32 - E33, presented at 82nd Congress of the European-Atherosclerosis-Society (EAS), SPAIN, Spanish Soc Atherosclerosis, Madrid, 31 May 2014 - 03 June 2014, http://dx.doi.org/10.1016/j.atherosclerosis.2014.05.065

Weise CB; Toth CL; Landstreet SR; Taylor RC; Tabet F; Rye KA; Hofmeister LH; Harrison DG; Kon V; Vickers K, 2014, 'NOVEL HDL FUNCTIONS ASSOCIATED WITH INTERCELLULAR COMMUNICATION, ATHEROSCLEROSIS, AND CHRONIC KIDNEY DISEASE', in ATHEROSCLEROSIS, ELSEVIER IRELAND LTD, SPAIN, Spanish Soc Atherosclerosis, Madrid, pp. E22 - E22, presented at 82nd Congress of the European-Atherosclerosis-Society (EAS), SPAIN, Spanish Soc Atherosclerosis, Madrid, 31 May 2014 - 03 June 2014, http://dx.doi.org/10.1016/j.atherosclerosis.2014.05.032

Kontush A; Camont L; Lhomme M; Rached F; Le Goff W; Dauteuille C; Baudouin IG; Negre-Salvayre A; Salvayre R; Calzada C; Lagarde M; Rye KA; Chapman MJ, 2014, 'PHOSPHATIDYLSERINE: A KEY PLAYER IN MULTIPLE BIOLOGICAL ACTIVITIES OF HDL', in ATHEROSCLEROSIS, ELSEVIER IRELAND LTD, SPAIN, Spanish Soc Atherosclerosis, Madrid, pp. E32 - E32, presented at 82nd Congress of the European-Atherosclerosis-Society (EAS), SPAIN, Spanish Soc Atherosclerosis, Madrid, 31 May 2014 - 03 June 2014, http://dx.doi.org/10.1016/j.atherosclerosis.2014.05.064

Charlton FS; Bobek G; Mirabito K; Xu B; Makris A; Rye K; Hennessy A, 2013, 'THE PROTECTIVE EFFECT OF APOLIPOPROTEIN A-I ON MEAN ARTERIAL PRESSURE IN AN IN VIVO MODEL OF CYTOKINE-INDUCED HYPERTENSION IN PREGNANCY', in HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, AUSTRALIA, Melbourne, pp. E145 - E145, presented at 35th Annual Scientific Meeting of the High-Blood-Pressure-Research-Council-of-Australia (HBPRCA) / 39th Annual Scientific Meeting of the Australian-Atherosclerosis-Society (AAS), AUSTRALIA, Melbourne, 05 December 2013 - 07 December 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000335491900022&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Tabet F; Lee S; Torres CL; Levin M; Drummond GR; Remaley A; Rye KA; Vickers K; Sobey CG, 2013, 'TRANSCRIPTIONAL AND POST-TRANSCRIPTIONAL CIRCUITRY IN THE BRAIN AFTER TRANSIENT AND PERMANENT ISCHEMIA', in HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, AUSTRALIA, Melbourne, pp. E157 - E158, presented at 35th Annual Scientific Meeting of the High-Blood-Pressure-Research-Council-of-Australia (HBPRCA) / 39th Annual Scientific Meeting of the Australian-Atherosclerosis-Society (AAS), AUSTRALIA, Melbourne, 05 December 2013 - 07 December 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000335491900076&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Bisoendial R; Roediger B; Jain R; Cavanagh L; Tak P-P; Rye K-A; Weninger W, 2013, 'TARGETING LYMPHATIC DYSFUNCTION IN RHEUMATOID ARTHRITIS BY HIGH-DENSITY LIPOPROTEIN', in ANNALS OF THE RHEUMATIC DISEASES, BMJ PUBLISHING GROUP, pp. 195 - 195

Arsenault BJ; Huijgen R; Boekholdt SM; Bao W; Tabet F; Petrides F; Rye K-A; DeMicco DA; Barter PJ; Kastelein JJ; Lambert G, 2011, 'Plasma PCSK9 Levels and Clinical Outcomes in the Treating to New Targets Trial: A Nested Case-Control Study', in CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000299738706056&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Charlton F; Xu B; Makris A; Rye K; Hennessy A, 2011, 'High density lipoproteins restore integrin switching in a model of pre-eclampsia', in Placenta, W B Saunders Company Ltd, London, England, pp. A94 - A94, presented at Meeting of the International-Federation-of-Placenta-Associations (IFPA), Geilo NORWAY, 14 September 2011 - 17 September 2011

Charlton F; Xu B; Makris A; Rye K; Hennessy A, 2011, 'Protective effects of high density lipoproteins in a model of pre-eclampsia', in Placenta, W B Saunders Company Ltd, London, England, pp. A94 - A94, presented at Meeting of the International-Federation-of-Placenta-Associations (IFPA), Geilo NORWAY, 14 September 2011 - 17 September 2011

Fryirs MA; Barter PJ; Appavoo M; Tuch B; Tabet F; Heater AK; Rye KA, 2009, 'High Density Lipoproteins Increase the Insulin Secretory Capacity of Pancreatic beta-Cells', in DIABETES, AMER DIABETES ASSOC, LA, New Orleans, pp. A426 - A426, presented at 69th Annual Meeting of the American-Diabetes-Association, LA, New Orleans, 05 June 2009 - 09 June 2009, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000266352602394&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Fryirs M; Barter P; Tabet F; Heather A; Rye K, 2009, 'HIGH DENSITY LIPOPROTEINS (HDL) INCREASE PANCREATIC B-CELL INSULIN SECRETION', in ATHEROSCLEROSIS SUPPLEMENTS, ELSEVIER IRELAND LTD, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000207957101052&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Heather A; Li X-H; McGrath K; Rye K; Barter P, 2009, 'HIGH DENSITY LIPOPROTEINS (HDLS) INDUCE A MILD OXIDATIVE STRESS RESPONSE IN HUMAN ENDOTHELIAL CELLS THAT INCREASES CELLULAR ANTIOXIDANT PROTEIN EXPRESSION AND PROTECTS AGAINST INFLAMMATORY INSULT', in ATHEROSCLEROSIS SUPPLEMENTS, ELSEVIER IRELAND LTD, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000207957101065&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Liong E; McGrath K; Tan J; Li X-H; Dy V; Barter P; Rye K; Heather A, 2009, 'ROLE OF 3B-HYDROXYSTEROID-[DELTA]24 REDUCTASE IN MEDIATING THE ANTI-INFLAMMATORY EFFECTS OF HIGH-DENSITY LIPOPROTEINS IN ENDOTHELIAL CELLS', in ATHEROSCLEROSIS SUPPLEMENTS, ELSEVIER IRELAND LTD, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000207957101118&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Tabet F; Remaley A; Barter P; Rye K-A; Lambert G, 2009, 'THE 5A APOA-I MIMETIC PEPTIDE DISPLAYS ANTI-INFLAMMATORY AND ANTIOXIDANT PROPERTIES MEDIATED BY ABCA1', in ATHEROSCLEROSIS SUPPLEMENTS, ELSEVIER IRELAND LTD, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000207957101675&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Tabet F; Lambert G; Jenkins A; Barter P; Rye K-A, 2009, 'THE ANTI-INFLAMMATORY AND ANTIOXIDANT PROPERTIES OF APOLIPOPROTEIN (APO) A-I FROM DIABETIC PATIENTS ARE IMPAIRED', in ATHEROSCLEROSIS SUPPLEMENTS, ELSEVIER IRELAND LTD, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000207957100913&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Tabet F; Barter PJ; Rye K-A, 2008, 'Apolipoprotein A-I and reconstituted high-density lipoproteins inhibit NADPH oxidase activation and expression and increase superoxide dismutase levels in human macrophages in high glucose conditions', in ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, LIPPINCOTT WILLIAMS & WILKINS, GA, Atlanta, pp. E87 - E87, presented at 9th Annual Conference on Arteriosclerosis, Thrombosis and Vascular Biology, GA, Atlanta, 16 April 2008 - 18 April 2008, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000256053400306&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Uehara Y; Zhang B; Tsuboi Y; Miura S; Abe S; Higuchi M; Urata H; Rye KA; Yamada T; Saku K, 2006, 'A novel therapeutic strategy for Tangier disease', in ATHEROSCLEROSIS SUPPLEMENTS, ELSEVIER IRELAND LTD, ITALY, Rome, pp. 562 - 562, presented at 14th Meeting of the International-Society-of-Atherosclerosis, ITALY, Rome, 18 June 2006 - 22 June 2006, http://dx.doi.org/10.1016/S1567-5688(06)82269-5

Gelissen I; Harris M; Rye KA; Quinn CM; Brown AJ; Kockx M; Cartland S; Packianathan M; Kritharides L; Jessup W, 2006, 'ABCA1 and ABCG1 act sequentially to mediate cholesterol export to apoA-I', in ATHEROSCLEROSIS SUPPLEMENTS, ELSEVIER IRELAND LTD, ITALY, Rome, pp. 541 - 541, presented at 14th Meeting of the International-Society-of-Atherosclerosis, ITALY, Rome, 18 June 2006 - 22 June 2006, http://dx.doi.org/10.1016/S1567-5688(06)82178-1

Taylor J; Rye KA; Sloane T; Gaus K; Ruberu K; Jessup W; Kritharides L, 2006, 'Exogenous apolipoprotein A-I promotes faecal sterol excretion in hypercholesterolemic rabbits', in ATHEROSCLEROSIS SUPPLEMENTS, ELSEVIER IRELAND LTD, ITALY, Rome, pp. 167 - 167, presented at 14th Meeting of the International-Society-of-Atherosclerosis, ITALY, Rome, 18 June 2006 - 22 June 2006, http://dx.doi.org/10.1016/S1567-5688(06)80653-7

Barter PJ; Rye KA, 2006, 'The rationale for using apoA-I as a clinical marker of cardiovascular risk', in Journal of Internal Medicine, pp. 447 - 454, http://dx.doi.org/10.1111/j.1365-2796.2006.01647.x

Kockx M; Wright J; Sloane T; Sviridov D; Fu Y; Chaddha M; Anantharamaiah G; Phillips M; Dean R; Rye K; Jessup W; Kritharides L, 2003, 'Apolipoprotein A-I-mediated secretion of apolipoprotein E has structural requirements distinct from those related to stimulation of cholesterol efflux', in ATHEROSCLEROSIS SUPPLEMENTS, ELSEVIER SCI IRELAND LTD, JAPAN, KYOTO, pp. 70 - 71, presented at 13th International Symposium on Atherosclerosis, JAPAN, KYOTO, 28 September 2003 - 02 October 2003, http://dx.doi.org/10.1016/S1567-5688(03)90303-5

James M; vanReyk D; Rye K; Dean R; Cleland L; Barter P; Jessup W, 1998, 'Low density lipoprotein (LDL) in human inflammatory joint fluid.', in FASEB JOURNAL, FEDERATION AMER SOC EXP BIOL, pp. A487 - A487, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000076006402828&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Barter PJ; Chang LBF; Newnham HH; Rye KA; Rajaram OV, 1990, 'Roles of lecithin: Cholesterol acyltransferase, lipid transfer proteins and nonesterified fatty acids in plasma cholesterol transport', in Journal of Drug Development, Supplement, pp. 85 - 89


Back to profile page